Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1992-4-14
pubmed:abstractText
Leukoregulin (LR) is a novel T-cell derived cytokine with unique anti-tumor properties. We have recently demonstrated that LR is also able to modulate the biosynthetic repertoire of normal human skin fibroblasts in culture (Mauviel, A., Rédini, F., Hartmann, D.J., Pujol, J.-P., and Evans, C.H. (1991) J. Cell Biol. 113, 1455-1462). In this study, we have examined in detail the effects of LR on collagenase gene expression in human skin fibroblast cultures. The results indicated time- and dose-dependent induction of collagenase mRNA steady-state levels, the maximum elevation being approximately 35-fold. In contrast, the mRNA levels for tissue inhibitor of metalloproteases remained unchanged in the same RNA preparations. The enhancement of collagenase mRNA levels was shown to be dependent on protein synthesis, and it could be counteracted by dexamethasone or all-trans-retinoic acid. Transient transfections of cultured fibroblasts with a human collagenase promoter/reporter gene construct indicated up-regulation of the promoter activity, which could be blocked by dexamethasone and all-trans-retinoic acid. The observation suggested regulation at the transcriptional level of collagenase gene expression. LR was also shown to induce the mRNA levels for junB, suggesting possible involvement of the AP-1 complex in the regulation. The ability of LR to selectively induce collagenase gene expression in skin fibroblasts suggests that this cytokine may significantly contribute to the degradation of the extracellular matrix in physiological situations, such as tissue development and repair, and in diseases characterized by excessive degradation and turnover of collagen.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
267
pubmed:geneSymbol
c-jun, junB
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5644-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1372007-3T3 Cells, pubmed-meshheading:1372007-Adult, pubmed-meshheading:1372007-Animals, pubmed-meshheading:1372007-Blotting, Northern, pubmed-meshheading:1372007-Cells, Cultured, pubmed-meshheading:1372007-Dexamethasone, pubmed-meshheading:1372007-Fibroblasts, pubmed-meshheading:1372007-Gene Expression Regulation, Enzymologic, pubmed-meshheading:1372007-Genes, jun, pubmed-meshheading:1372007-Humans, pubmed-meshheading:1372007-Infant, Newborn, pubmed-meshheading:1372007-Lymphokines, pubmed-meshheading:1372007-Mice, pubmed-meshheading:1372007-Microbial Collagenase, pubmed-meshheading:1372007-Promoter Regions, Genetic, pubmed-meshheading:1372007-RNA, pubmed-meshheading:1372007-RNA, Messenger, pubmed-meshheading:1372007-Skin, pubmed-meshheading:1372007-Transcription, Genetic, pubmed-meshheading:1372007-Transfection, pubmed-meshheading:1372007-Tretinoin
pubmed:year
1992
pubmed:articleTitle
Transcriptional activation of fibroblast collagenase gene expression by a novel lymphokine, leukoregulin.
pubmed:affiliation
Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't